{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1170.6","meta":{"versionId":"10","lastUpdated":"2023-02-18T01:03:13.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Yale Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-02-18"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-02-18"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1170.6"}],"version":"20230218","name":"ThrombolyticsAdverseEvent","title":"Thrombolytics Adverse Event","status":"active","date":"2023-02-18T01:03:13-05:00","publisher":"Yale","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for adverse reactions to thrombolytic medications used for treatment of ST-segment elevation myocardial infaction (STEMI).),(Data Element Scope: This value set may use a model element related to Disorder.),(Inclusion Criteria: Includes SNOMED-CT codes that represent adverse reactions to thrombolytic medications for STEMI treatment.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"218568007","display":"Adverse reaction caused by fibrinolytic drugs (disorder)"},{"code":"293571007","display":"Streptokinase adverse reaction (disorder)"},{"code":"293572000","display":"Urokinase adverse reaction (disorder)"},{"code":"293573005","display":"Alteplase adverse reaction (disorder)"},{"code":"293574004","display":"Anistreplase adverse reaction (disorder)"}]}]},"expansion":{"identifier":"urn:uuid:73414fa8-60a6-4f86-b2c7-025abe7f9783","timestamp":"2023-12-10T22:35:34-05:00","total":5,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"218568007","display":"Adverse reaction caused by fibrinolytic drugs (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"293571007","display":"Streptokinase adverse reaction (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"293572000","display":"Urokinase adverse reaction (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"293573005","display":"Alteplase adverse reaction (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"293574004","display":"Anistreplase adverse reaction (disorder)"}]}}